Results 171 to 180 of about 34,144 (356)

Detection of SARS-CoV-2 in Ascitic Fluid of Cirrhotic COVID-19 Patients: Case Series and Literature Review [PDF]

open access: diamond
Grazia Caci   +14 more
openalex   +1 more source

Third‐Generation EGFR‐TKIs Combined With Chemotherapy in Advanced Non‐Small Cell Lung Cancer: A Real‐World Study

open access: yesCancer Science, EarlyView.
This study was the largest sample size of first‐line third‐generation TKIs combined chemotherapy among advanced EGFRm NSCLC patients in the real world. It was never reported that aumolertinib and furmonertinib showed comparable PFS benefits to osimertinib in combination with chemotherapy. The overall safety profile remained acceptable. ABSTRACT FLAURA2
YuQin Jiang   +9 more
wiley   +1 more source

Primary ascitic fluid infection in patients with chronic liver diseases

open access: yesThe Saudi Journal of Gastroenterology, 2001
The aim of the study: to evaluate primary ascitic fluid infection (PAFI) among patients with chronic liver disease (CLD), to study the incidence, clinical features, laboratory findings and short term prognosis of PAFI and also to evaluate factors that ...
Khalaf Abdul-Raheem, AL-Myahi Mohammed
doaj  

CRISPR Activation Reveals the Spliceogenicity of an Intronic NEB Variant in Fetuses With Arthrogryposis Multiplex Congenita 6

open access: yesClinical Genetics, EarlyView.
CRISPR activation of NEB in fibroblasts, followed by RNA‐sequencing, documents spliceogenic effects of a NEB intronic variant. The assay enabled variant reclassification as likely pathogenic, providing molecular diagnosis in fetuses with Arthrogryposis multiplex congenita 6.
Doriana Misceo   +7 more
wiley   +1 more source

Variants of Ascitic Fluid Bacterial Infection in Children with Chronic Liver Disease in a tertiary care hospital in Bangladesh

open access: diamond, 2021
Md Liaquat Ali   +6 more
openalex   +1 more source

Dasatinib Produces Lengthy Remissions of Extramedullary Leukemia: A Retrospective Observational Study

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Since 2004, patients receiving imatinib with relapse in non‐marrow sites were given dasatinib to preserve control of leukemic marrow. Remissions in CNS and other organs began to be reported and are continuously observed to present. With resistance to one BCR::ABL1 tyrosine kinase inhibitor and sensitivity to a dual BCR::ABL1/SRC inhibitor ...
I. Cunningham   +4 more
wiley   +1 more source

Friend Leukemogenic Virus-neutralizing Antibody from Mouse Ascitic Fluid

open access: diamond, 1967
Ricard March   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy